Higher doses might be required in leukemia cells to inhibit mTOR binding to RICTOR, but we did not detect any decrease in AKT pSer473 levels following treatment of Jurkat cells with up to 50 μM JR-AB2-011 (Fig. 3b). The gene discussed is MTOR; the disease is leukemia.